ImClone will keep 39 per cent of US revenues from Erbitux, with Bristol-Myers Squibb taking the rest.
英克隆将提留西妥昔单抗在美收入的39%，而百时美施贵宝将获得其余部分。
The bosses of both Genentech and ImClone have unceremoniously rejected the offers made by their partners.
基因技术公司和从英克隆公司的老板都随随便便地就拒绝了收购的出价。
And ImClone Systems Inc's cancer drug Erbitux carries a warning due to serious and sometimes fatal reactions in about 3 percent of patients.
而英克隆系统公司的抗癌药物Erbitux引起警告是由于百分之三左右的患者中存在严重并且有时甚至致命的反应。
The tussle over ImClone has been an altogether messier affair, thanks to Carl Icahn, a legendary corporate raider who owns a stake and is chairman of the firm.
卡尔·伊坎的加入使得争夺艾克隆公司的战争更加惨烈。卡尔·伊坎是擅长掠夺式收购的传奇人物，他掌控着该公司的一部分股份，并出任公司董事长。
The tussle over ImClone has been an altogether messier affair, thanks to Carl Icahn, a legendary corporate raider who owns a stake and is chairman of the firm.
卡尔·伊坎的加入使得争夺艾克隆公司的战争更加惨烈。卡尔·伊坎是擅长掠夺式收购的传奇人物，他掌控着该公司的一部分股份，并出任公司董事长。
应用推荐